<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="52019">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01995630</url>
  </required_header>
  <id_info>
    <org_study_id>SIOLvsAIOL</org_study_id>
    <nct_id>NCT01995630</nct_id>
  </id_info>
  <brief_title>Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients</brief_title>
  <official_title>Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate differences in the depth of focus after
      implantation of a spherical or aspheric IOL in hypermetropic and emmetropic patients. After
      implantation of a spherical IOL hypermetropic patients may achieve a better depth of focus
      compared to emmetropic patients due to a larger amount of spherical aberrations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Distance-corrected intermediate visual acuity</measure>
    <time_frame>3 month postop</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Distance-corrected near visual acuity</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected distance visual acuity</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corrected distance visual acuity</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected near visual acuity</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corrected near visual acuity</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pseudoaccomodation</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Photopic contrast sensitivity</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mesopic contrast sensitivity</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spherical aberrations</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High order aberrations</measure>
    <time_frame>3 month postop</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Cataract</condition>
  <condition>Spherical Aberrations</condition>
  <condition>Intraocular Lenses</condition>
  <condition>Depth of Focus</condition>
  <arm_group>
    <arm_group_label>Hypermetropic, spherical IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AMO Sensar AR40e</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypermetropic, aspheric IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AMO Tecnis ZA9003</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Emmetropic, spherical IOL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AMO Sensar AR40e</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Emmetropic, aspheric IOL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AMO Tecnis ZA9003</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AMO Tecnis ZA9003</intervention_name>
    <arm_group_label>Hypermetropic, aspheric IOL</arm_group_label>
    <arm_group_label>Emmetropic, aspheric IOL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AMO Sensar AR40e</intervention_name>
    <arm_group_label>Hypermetropic, spherical IOL</arm_group_label>
    <arm_group_label>Emmetropic, spherical IOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cataract

          -  Dioptric power of IOL &gt;22.0 D in hypermetropic patients and 18.0-22.0 D in emmetropic
             patients, respectively

        Exclusion Criteria:

          -  Uveitis, pathology of the retina or the optic nerve

          -  Corneal scarring or irregularities

          -  Astigmatism &gt;1.5 D

          -  Amblyopia

          -  Perioperative complications

          -  Postoperative refractive error &gt;2.0 D of spherical equivalent

          -  Postoperative DCVA &lt;0.8 (ETDRS)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Navid Ardjomand, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Ophthalmology, Medical University of Graz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Navid Ardjomand, MD</last_name>
    <phone>0043 316 385 80704</phone>
    <email>navid.ardjomand@medunigraz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gernot Steinwender, MD</last_name>
    <phone>0043 316 385 81130</phone>
    <email>steinwender.gernot@gmx.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Ophthalmology, Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Navid Ardjomand, MD</last_name>
      <phone>0043 316 385 80704</phone>
      <email>navid.ardjomand@medunigraz.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 21, 2013</lastchanged_date>
  <firstreceived_date>November 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Graz</investigator_affiliation>
    <investigator_full_name>Navid Ardjomand</investigator_full_name>
    <investigator_title>Univ.-Doz. Dr. med. univ.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
